PRKAB2 as a tumor suppressor in renal cell carcinoma: inhibiting mitophagy via the LRPPRC-PRKN/parkin interaction and cardiolipin biosynthesis. Here, LRPPRC is linked to hereditary clear cell renal cell carcinoma.